Description
Monitorizar efectos adversos gastrointestinales y cardiovasculares
Alteraciones gastrointestinales
Usar solo bajo supervisión médica
TRESIBAFLEXTO + B439:B534 UC100 U/ML | Solución Inyectable | 5 x 3 mL | Roche
PRINCIPIO ACTIVO: CINARIZINA
NIDAL 2 BEBE FORMLACT 6-12M 1.1KG FOSFATO BETAMETASONA Monitorizar efectos adversos gastrointestinales y
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
